DRW Securities’s DexCom DXCM Stock Holding History

DRW Securities’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-60,000	Closed	-$5.6M	–	354
2023 Q3	$5.6M	Buy	+60,000	New	+$6.76M	0.11%	54

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DRW Securities's DXCM Position: Q1 2026 in Review

DRW Securities sold out of DexCom (DXCM) in Q1 2026, closing a stake of 3,096 shares — an estimated $205K sold.

DRW Securities first reported a position in DXCM in Q3 2023 and held it in 3 quarters. The position peaked at $4.54M in Q3 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

DRW Securities reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 3,096 DexCom shares in Q1 2026, an estimated $205K.
DRW Securities first reported a position in DexCom in Q3 2023 and held it in 3 quarters.
DRW Securities's DexCom position peaked at $4.54M in Q3 2023.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.